News

Mosaic (NYSE:MOS) executives said the company is cutting costs, curtailing some phosphate production and reducing capital spending as geopolitical disruptions drive raw material shortages and pressure fertilizer industry margins. On the company’s first-quarter 2026 earnings call, President and Chie

Hims & Hers Health (NYSE:HIMS) reported first-quarter 2026 revenue growth and raised its full-year revenue outlook, while executives said a strategic shift in the company’s weight-loss business is creating short-term margin pressure and volatility in GAAP results. On the company’s earnings call

Babcock (NYSE:BW) reported a sharply stronger first quarter of 2026, with management pointing to rising demand for power generation from utilities, industrial customers and AI data centers as a key driver of growth. Chairman and CEO Kenneth Young said on the company’s earnings call that the quarter

Archer Aviation (NYSE:ACHR) executives said the company is increasing investment across its civil air taxi, defense and aviation software efforts as it advances aircraft certification, prepares for U.S. test operations and develops a new hybrid aircraft with defense technology company Anduril. On t

POET Technologies Inc. (NASDAQ:POET) is one of the 10 Stocks With Easy Double-Digit Returns. POET Technologies rallied for a second day on Monday, climbing 27.09 percent to close at $13.90 apiece, as investors resumed buying positions ahead of the results of its earnings performance this week. Based on its historical reporting dates, POET Technologies Inc. […]

WEBTOON Entertainment (NASDAQ:WBTN) reported first-quarter 2026 revenue that declined slightly from a year earlier, while profitability improved as the digital comics and storytelling platform cited stronger gross margins, cost discipline and growth in paying users. Founder and CEO Junkoo Kim said

Rigetti Computing (NASDAQ:RGTI) reported higher first-quarter 2026 revenue and highlighted the launch of its 108-qubit Cepheus-1-108Q system as management emphasized customer adoption, ongoing fidelity improvements and a sizable cash position to fund its quantum computing roadmap. Chief Executive S

Quantum Computing (NASDAQ:QUBT) reported a sharp year-over-year increase in first-quarter revenue as recent acquisitions began contributing to results, while management outlined plans to expand manufacturing capabilities and advance its quantum photonics product roadmap. On the company’s first-quar

Thank you for attending the Babcock & Wilcox Enterprises First Quarter 2026 Conference Call. You may proceed, Ms. Brooks. Sharyn Brooks: Thank you, Allen, and thanks to everyone for joining us on Babcock & Wilcox Enterprises First Quarter 2026 Earnings Conference Call.

Plug Power (NASDAQ:PLUG) reported higher first-quarter revenue and a narrower gross loss as management said cost cuts, stronger electrolyzer activity and improving hydrogen fuel economics supported progress toward its 2026 profitability targets. On the company’s 2026 first-quarter earnings call, CE

Marathon Digital (NASDAQ:MARA) executives said the company used the first quarter of fiscal 2026 to accelerate its shift from a pure-play Bitcoin miner toward a broader digital infrastructure business focused on power-backed AI, high-performance computing and critical IT workloads. Chairman and CEO

There's a version of Walmart most people still picture. Fluorescent lights, crowded aisles, maybe a cart with a wobbly wheel. That version still exists. But the company Wall Street is paying 43 times forward earnings for? That's a different beast entirely.As of 2026, Walmart is a 63-year-old ...

Halozyme Therapeutics (NASDAQ:HALO) reported a sharp increase in first-quarter 2026 revenue and earnings, driven by continued growth in royalties from its ENHANZE drug-delivery platform, and announced a new $1 billion share repurchase authorization. On the company’s earnings call, President and CEO

Almonty Industries Inc. (ALM) delivered earnings and revenue surprises of +33.33% and +19.90%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ares Management’s first quarter saw strong revenue growth, with management attributing performance to robust institutional fundraising and broad-based product demand across its credit, real assets, and secondaries platforms. CEO Michael J. Arougheti emphasized that, despite a seasonal slowdown and geopolitical uncertainty, the firm’s deployment and fundraising remained resilient. He highlighted that “our pipeline of new institutional funds remains robust for this year and next year,” supporting

Traders are piling into this AI data-center pivot even as fresh earnings highlight execution risks, today, May 11, 2026.

AST SpaceMobile (NASDAQ:ASTS) said it remains on track with its 2026 deployment and revenue plans as the satellite-to-smartphone company works to scale manufacturing, launch additional BlueBird satellites and move closer to commercial service activation in key markets. On the company’s first-quarte

Cleanspark (NASDAQ:CLSK) reported fiscal second-quarter 2026 results while emphasizing its ongoing shift from a bitcoin mining-focused operator toward a broader digital infrastructure and data center development platform aimed at serving artificial intelligence and high-performance computing demand.

AbCellera Biologics (NASDAQ:ABCL) said its first quarter of 2026 was marked by progress in its internal drug pipeline, including interim Phase 1 data for its lead program, ABCL635, and continued preparation for multiple clinical catalysts expected over the next two years. President and CEO Dr. Carl

Additionally, there are billions of people without cellular broadband and who remain unconnected to the global economy. The markets we are pursuing at AST SpaceMobile, Inc. are massive; the problem we are solving is important and touches nearly all of us. In this backdrop, AST SpaceMobile, Inc. is building the first and only global cellular broadband network in space to operate directly with everyday unmodified mobile devices, supported by our extensive IP and patent portfolio.

Shares of Quantum Computing Inc. fell 38% last year, but first-quarter earnings mark a shift in investor sentiment.

Subodh Kulkarni: Good afternoon, and thank you for joining us for Rigetti Computing, Inc.'s first quarter 2026 earnings conference call. Before we begin, I would like to remind everyone that today’s call, along with our first quarter 2026 press release, contains forward-looking statements.

Tryn Stimart: Thank you for joining us for AbCellera Biologics Inc.'s First Quarter 2026 Earnings Call. Doctor Carl L. Hansen, AbCellera Biologics Inc.'s President and CEO, Doctor Sarah Noonberg, AbCellera Biologics Inc.'s Chief Medical Officer, and Andrew Booth, AbCellera Biologics Inc.'s Chief Financial Officer, are speaking on today's call.

Matthew Schultz: Thank you, Harry, and thank you everyone for joining us this afternoon. This quarter represents continued meaningful progress in CleanSpark, Inc.’s evolution into a digital infrastructure and data center development company, one that utilizes our heritage as energy natives, builds on the strength of our mining operations, and ultimately expands the set of opportunities our portfolio can support. AI is different because it is compute denominated, and compute is a function of access to energy and data center infrastructure.

On May 11, 2026, investors weighed Archer's solid Q1 earnings versus the company's cash burn and rising eVTOL competition.

Novanta (NOVT) delivered earnings and revenue surprises of +3.85% and +1.70%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

CleanSpark (CLSK) delivered earnings and revenue surprises of -110.78% and -0.13%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

CI&T (CINT) delivered earnings and revenue surprises of -29.41% and +1.58%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cleanspark reported fiscal second quarter revenue of $136.4 million, down 24.9% year over year, while its net loss more than doubled as the miner advances AI/HPC infrastructure plans.

While the top- and bottom-line numbers for Halozyme Therapeutics (HALO) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.